Mutational analysis of JAK2V617F in tunisian polycythemia vera patients

被引：0
|
作者：
Frikha, R. [2 ]
Elloumi, M. [1 ]
Kamoun, H. [2 ]
机构：
[1] Hosp Hedi Chaker Sfax, Dept Hematol, Sfax, Tunisia
[2] Hosp Hedi Chaker Sfax, Dept Med Genet, Sfax, Tunisia
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118357
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P0786
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera
    Kuriakose, Emil
    Vandris, Katherine
    Wang, Y. Lynn
    Chow, William
    Jones, Amy V.
    Christos, Paul
    Cross, Nicholas C. P.
    Silver, Richard T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (04): : 538 - 542
  • [22] MOLECULAR PROFILE AND RISK OF THROMBOSIS IN A SERIES OF PATIENTS WITH POLYCYTHEMIA VERA WITH JAK2V617F MUTATION
    Angona, A.
    Corbizi, G.
    Fernandez-Rodriguez, C.
    Gibert, J.
    Fernandez, L.
    Camacho, L.
    Garcia Gisbert, N.
    Garcia Pallarols, F.
    Longaron, R.
    Salar, A.
    Besses, C.
    Bellosillo, B.
    HAEMATOLOGICA, 2019, 104 : 61 - 61
  • [23] Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
    Schnittger, Susanne
    Bacher, Ulrike
    Haferlach, Claudia
    Geer, Thomas
    Mueller, Peter
    Mittermueller, Johann
    Petrides, Petro
    Schlag, Rudolf
    Sandner, Reiner
    Selbach, Johannes
    Slavvik, Hans Rainer
    Tessen, Hans Werner
    Wehmeyer, Juergen
    Kern, Wolfgang
    Haferlach, Torsten
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (03): : 414 - 418
  • [24] Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
    A Tefferi
    J J Strand
    T L Lasho
    R A Knudson
    C M Finke
    N Gangat
    A Pardanani
    C A Hanson
    R P Ketterling
    Leukemia, 2007, 21 : 2074 - 2075
  • [25] Influence of JAK2V617F Allele Burden on Hematological Response in the Treatment of Polycythemia Vera
    Shikhbabaeva, Dzhariyat
    Shuvaev, Vasily
    Golovchenko, Regina
    Udaleva, Vera
    Fominykh, Mikhail
    Zotova, Irina I.
    Polushkina, Lyubov
    Martynkevich, Irina
    Abdulkadyrov, Kudrat
    BLOOD, 2016, 128 (22)
  • [26] Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera
    Rossi, davide
    Cortini, Francesca
    Deambrogi, Clara
    Barbieri, Caterina
    Cerri, Michaela
    Franceschetti, Silvia
    Conconi, Annarita
    Capello, Daniela
    Gaidano, Gianluca
    LEUKEMIA RESEARCH, 2007, 31 (01) : 97 - 101
  • [27] Identification of two novel mutations besides JAK2V617F in a patient with polycythemia vera
    Xie, X.
    Koffke-Marchant, K.
    Lichtin, A.
    Palinchik, K.
    Jakubowski, M.
    Murugesan, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 670 - 670
  • [28] Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth
    Li, Zhe
    Xu, Mingjiang
    Xing, Shu
    Ho, Wanting Tina
    Ishii, Takefumi
    Li, Qingshan
    Fu, Xueqi
    Zhao, Zhizhuang Joe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) : 3428 - 3432
  • [29] The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera
    Falchi, Mario
    Varricchio, Lilian
    Martelli, Fabrizio
    Marra, Manuela
    Picconi, Orietta
    Tafuri, Agostino
    Girelli, Gabriella
    Uversky, Vladimir N.
    Migliaccio, Anna Rita
    EXPERIMENTAL HEMATOLOGY, 2017, 50 : 53 - 76
  • [30] Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
    Tefferi, A.
    Strand, J. J.
    Lasho, T. L.
    Knudson, R. A.
    Finke, C. M.
    Gangat, N.
    Pardanani, A.
    Hanson, C. A.
    Ketterling, R. P.
    LEUKEMIA, 2007, 21 (09) : 2074 - 2075
12345